Tracey D. Graves
Huntingdon, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction to: Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.
Journal: Cerebellum (London, England)
Published: July 29, 2022
Research priorities for mitochondrial disorders: Current landscape and patient and professional views.
Journal: Journal of inherited metabolic disease
Published: January 19, 2022
Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.
Journal: Cerebellum (London, England)
Published: December 14, 2021
KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.
Journal: Brain : a journal of neurology
Published: May 15, 2020
Response to the paper titled "Identification of a novel CACNA1A mutation in a Chinese family with autosomal recessive progressive myoclonic epilepsy".
Journal: Neuropsychiatric disease and treatment
Published: September 27, 2018
Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child.
Journal: Neurogenetics
Published: October 14, 2016
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Journal: Brain : a journal of neurology
Published: March 01, 2014
Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 26, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026